In March 2009, international experts from academia, industry and government convened to discuss the scientific and clinical basis for the successes and failures of recombinant cytokines and cytokine antagonists as therapeutic agents, and possible strategies for improving their clinical success. This volume included extended versions of key presentations at the meeting.
Improved methods for identifying disease targets
Alternative methods for enhancing and targeting cytokine delivery
Physicochemical modification of cytokines to prolong their bioavailability
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit <a href="[external URL]
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (<a href="[external URL] Members of the New York Academy of Science receive full–text access to the Annals online and discounts on print volumes. Please visit <a href="[external URL] for more information about becoming a member.